{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T05:27:45Z","timestamp":1769923665470,"version":"3.49.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology Clinics of North America"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.gtc.2020.08.005","type":"journal-article","created":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T07:57:09Z","timestamp":1601020629000},"page":"791-807","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Risk of Colon Cancer and Recommended Surveillance Strategies in Patients with Ulcerative Colitis"],"prefix":"10.1016","volume":"49","author":[{"given":"Wendy","family":"Rabbenou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas A.","family":"Ullman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gtc.2020.08.005_bib1","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00000441-192508010-00006","article-title":"The sigmoidoscopic picture of chronic ulcerative colitis","volume":"170","author":"Crohn","year":"1925","journal-title":"Am J Med Sci"},{"issue":"6","key":"10.1016\/j.gtc.2020.08.005_bib2","first-page":"383","article-title":"Patients' knowledge and fear of colorectal cancer risk in inflammatory bowel disease","volume":"17","author":"Lopez","year":"2016","journal-title":"J\u00a0Dig Dis"},{"issue":"12","key":"10.1016\/j.gtc.2020.08.005_bib3","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/ajg.2013.249","article-title":"Cancer risk in inflammatory bowel disease according to patient phenotype and treatment: a Danish population-based cohort study","volume":"108","author":"Jess","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"18","key":"10.1016\/j.gtc.2020.08.005_bib4","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJM199011013231802","article-title":"Ulcerative colitis and colorectal cancer. A population-based study","volume":"323","author":"Ekbom","year":"1990","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.gtc.2020.08.005_bib5","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/gut.48.4.526","article-title":"The risk of colorectal cancer in ulcerative colitis: a meta-analysis","volume":"48","author":"Eaden","year":"2001","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.gtc.2020.08.005_bib6","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/S1542-3565(04)00543-9","article-title":"Long-term risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen County","volume":"2","author":"Winther","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.gtc.2020.08.005_bib7","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1053\/j.gastro.2012.04.016","article-title":"Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years","volume":"143","author":"Jess","year":"2012","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.gtc.2020.08.005_bib8","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1053\/j.gastro.2005.12.037","article-title":"Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota","volume":"130","author":"Jess","year":"2006","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.gtc.2020.08.005_bib9","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1053\/j.gastro.2013.03.044","article-title":"Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease","volume":"145","author":"Beaugerie","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2020.08.005_bib10","doi-asserted-by":"crossref","first-page":"5363261","DOI":"10.1155\/2019\/5363261","article-title":"Risk of colorectal cancer in ulcerative colitis patients: a systematic review and meta-analysis","volume":"2019","author":"Zhou","year":"2019","journal-title":"Gastroenterol Res Pract"},{"issue":"6","key":"10.1016\/j.gtc.2020.08.005_bib11","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.cgh.2012.01.010","article-title":"Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies","volume":"10","author":"Jess","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.gtc.2020.08.005_bib12","doi-asserted-by":"crossref","first-page":"384","DOI":"10.14309\/ajg.0000000000000152","article-title":"ACG clinical guideline: ulcerative colitis in adults","volume":"114","author":"Rubin","year":"2019","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.gtc.2020.08.005_bib13","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1053\/j.gastro.2009.12.037","article-title":"AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease","volume":"138","author":"Farraye","year":"2010","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.gtc.2020.08.005_bib14","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/gut.2009.179804","article-title":"Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002)","volume":"59","author":"Cairns","year":"2010","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.gtc.2020.08.005_bib15","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1053\/j.gastro.2009.12.035","article-title":"AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease","volume":"138","author":"Farraye","year":"2010","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.gtc.2020.08.005_bib16","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/0016-5085(92)90308-L","article-title":"Primary sclerosing cholangitis in ulcerative colitis--a risk factor for the development of dysplasia and DNA aneuploidy?","volume":"102","author":"Broome","year":"1992","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.gtc.2020.08.005_bib17","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1067\/mge.2002.125367","article-title":"Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis","volume":"56","author":"Soetikno","year":"2002","journal-title":"Gastrointest Endosc"},{"issue":"1","key":"10.1016\/j.gtc.2020.08.005_bib18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1056\/NEJM197107012850103","article-title":"Cancer risk and life expectancy of children with ulcerative colitis","volume":"285","author":"Devroede","year":"1971","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.gtc.2020.08.005_bib19","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z","article-title":"Cancer risk in patients with inflammatory bowel disease: a population-based study","volume":"91","author":"Bernstein","year":"2001","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.gtc.2020.08.005_bib20","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0016-5085(98)70077-0","article-title":"Familial predisposition for colorectal cancer in chronic ulcerative colitis: a case-control study","volume":"115","author":"Nuako","year":"1998","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.gtc.2020.08.005_bib21","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1053\/gast.2001.24052","article-title":"Family history as a risk factor for colorectal cancer in inflammatory bowel disease","volume":"120","author":"Askling","year":"2001","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.gtc.2020.08.005_bib22","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1053\/j.gastro.2010.02.007","article-title":"Inflammatory bowel disease confers a lower risk of colorectal cancer to females than to males","volume":"138","author":"Soderlund","year":"2010","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.gtc.2020.08.005_bib23","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/j.gastro.2003.11.010","article-title":"Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis","volume":"126","author":"Rutter","year":"2004","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.gtc.2020.08.005_bib24","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1053\/j.gastro.2007.08.001","article-title":"Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study","volume":"133","author":"Gupta","year":"2007","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.gtc.2020.08.005_bib25","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/gutjnl-2017-314190","article-title":"Cumulative burden of inflammation predicts colorectal neoplasia risk in ulcerative colitis: a large single-centre study","volume":"68","author":"Choi","year":"2019","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.gtc.2020.08.005_bib26","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1136\/gut.33.7.938","article-title":"Benign and malignant colorectal strictures in ulcerative colitis","volume":"33","author":"Gumaste","year":"1992","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.gtc.2020.08.005_bib27","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/BF01537413","article-title":"Dysplasia and cancer complicating strictures in ulcerative colitis","volume":"35","author":"Lashner","year":"1990","journal-title":"Dig Dis Sci"},{"issue":"10","key":"10.1016\/j.gtc.2020.08.005_bib28","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/j.cgh.2015.04.185","article-title":"Detection of dysplasia or cancer in 3.5% of patients with inflammatory bowel disease and colonic strictures","volume":"13","author":"Fumery","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.gtc.2020.08.005_bib29","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1053\/j.gastro.2006.03.028","article-title":"Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case-control study","volume":"130","author":"Velayos","year":"2006","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.gtc.2020.08.005_bib30","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1053\/j.gastro.2018.11.067","article-title":"No association between pseudopolyps and colorectal neoplasia in patients with inflammatory bowel diseases","volume":"156","author":"Mahmoud","year":"2019","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.gtc.2020.08.005_bib31","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1053\/j.gastro.2011.01.057","article-title":"Intestinal inflammation and cancer","volume":"140","author":"Ullman","year":"2011","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.gtc.2020.08.005_bib32","first-page":"11","article-title":"Precancer in ulcerative colitis: the role of the field effect and its clinical implications","volume":"39","author":"Baker","year":"2018","journal-title":"Carcinogenesis"},{"issue":"9","key":"10.1016\/j.gtc.2020.08.005_bib33","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1136\/gut.2007.143453","article-title":"High frequency of early colorectal cancer in inflammatory bowel disease","volume":"57","author":"Lutgens","year":"2008","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.gtc.2020.08.005_bib34","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00000658-198602000-00002","article-title":"A\u00a0comparison of multiple synchronous colorectal cancer in ulcerative colitis, familial polyposis coli, and de novo cancer","volume":"203","author":"Greenstein","year":"1986","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.gtc.2020.08.005_bib35","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1158\/0008-5472.CAN-10-1966","article-title":"Ulcerative colitis-associated colorectal cancer arises in a field of short telomeres, senescence, and inflammation","volume":"71","author":"Risques","year":"2011","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.gtc.2020.08.005_bib36","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0016-5085(94)90068-X","article-title":"Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study","volume":"107","author":"Pinczowski","year":"1994","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.gtc.2020.08.005_bib37","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1111\/j.1572-0241.2000.02297.x","article-title":"Colorectal cancer complicating ulcerative colitis: a review","volume":"95","author":"Eaden","year":"2000","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.gtc.2020.08.005_bib38","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/ibd.20074","article-title":"5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease","volume":"13","author":"Terdiman","year":"2007","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"10.1016\/j.gtc.2020.08.005_bib39","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s00384-002-0476-6","article-title":"Chemoprevention of colorectal cancer in ulcerative colitis","volume":"18","author":"Croog","year":"2003","journal-title":"Int J Colorectal Dis"},{"issue":"6","key":"10.1016\/j.gtc.2020.08.005_bib40","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1111\/j.1572-0241.2005.41442.x","article-title":"Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies","volume":"100","author":"Velayos","year":"2005","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"10.1016\/j.gtc.2020.08.005_bib41","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/ajg.2012.198","article-title":"5-aminosalicylic acid is not protective against colorectal cancer in inflammatory bowel disease: a meta-analysis of non-referral populations","volume":"107","author":"Nguyen","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"10.1016\/j.gtc.2020.08.005_bib42","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.cgh.2008.05.020","article-title":"Progression to colorectal neoplasia in ulcerative colitis: effect of mesalamine","volume":"6","author":"Ullman","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.gtc.2020.08.005_bib43","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1136\/gutjnl-2018-317021","article-title":"Stopping 5-aminosalicylates in patients with ulcerative colitis starting biologic therapy does not increase the risk of adverse clinical outcomes: analysis of two nationwide population-based cohorts","volume":"68","author":"Ungaro","year":"2019","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.gtc.2020.08.005_bib44","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/gut.2011.237412","article-title":"Thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease","volume":"61","author":"van Schaik","year":"2012","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.gtc.2020.08.005_bib45","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S1542-3565(05)00738-X","article-title":"Chemoprevention of colorectal neoplasia in ulcerative colitis: the effect of 6-mercaptopurine","volume":"3","author":"Matula","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.gtc.2020.08.005_bib46","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.cgh.2014.05.019","article-title":"Thiopurines and risk of colorectal neoplasia in patients with inflammatory bowel disease: a meta-analysis","volume":"12","author":"Jess","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.gtc.2020.08.005_bib47","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/apt.14436","article-title":"Systematic review with meta-analysis: thiopurines decrease the risk of colorectal neoplasia in patients with inflammatory bowel disease","volume":"47","author":"Lu","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.gtc.2020.08.005_bib48","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1158\/1940-6207.CAPR-09-0272","article-title":"Prevention of colitis-associated carcinogenesis with infliximab","volume":"3","author":"Kim","year":"2010","journal-title":"Cancer Prev Res (Phila)"},{"issue":"2","key":"10.1016\/j.gtc.2020.08.005_bib49","doi-asserted-by":"crossref","first-page":"89","DOI":"10.7326\/0003-4819-134-2-200101160-00008","article-title":"Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis","volume":"134","author":"Tung","year":"2001","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.gtc.2020.08.005_bib50","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1053\/gast.2003.50156","article-title":"Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis","volume":"124","author":"Pardi","year":"2003","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.gtc.2020.08.005_bib51","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1038\/ajg.2011.156","article-title":"High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis","volume":"106","author":"Eaton","year":"2011","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.gtc.2020.08.005_bib52","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0016-5085(89)90058-9","article-title":"Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis. A case-control study","volume":"97","author":"Lashner","year":"1989","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.gtc.2020.08.005_bib53","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0016-5085(97)70215-4","article-title":"The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis","volume":"112","author":"Lashner","year":"1997","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.gtc.2020.08.005_bib54","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/gut.8.5.423","article-title":"Rectal biopsy as an aid to cancer control in ulcerative colitis","volume":"8","author":"Morson","year":"1967","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.gtc.2020.08.005_bib55","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/0016-5085(92)91185-7","article-title":"DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis","volume":"103","author":"Rubin","year":"1992","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.gtc.2020.08.005_bib56","first-page":"2106","article-title":"Physicians' perceptions of dysplasia and approaches to surveillance colonoscopy in ulcerative colitis","volume":"90","author":"Bernstein","year":"1995","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.gtc.2020.08.005_bib57","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0016-5107(00)70405-6","article-title":"How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis of performance","volume":"51","author":"Eaden","year":"2000","journal-title":"Gastrointest Endosc"},{"issue":"3","key":"10.1016\/j.gtc.2020.08.005_bib58","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s10350-003-0049-y","article-title":"Surveillance for dysplasia in patients with inflammatory bowel disease: a national survey of colonoscopic practice in New Zealand","volume":"47","author":"Gearry","year":"2004","journal-title":"Dis Colon Rectum"},{"issue":"2","key":"10.1016\/j.gtc.2020.08.005_bib59","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3748\/wjg.15.226","article-title":"Adherence to surveillance guidelines for dysplasia and colorectal carcinoma in ulcerative and Crohn's colitis patients in the Netherlands","volume":"15","author":"van Rijn","year":"2009","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.gtc.2020.08.005_bib60","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.gie.2011.06.028","article-title":"Progression of low-grade dysplasia in ulcerative colitis: effect of colonic location","volume":"74","author":"Goldstone","year":"2011","journal-title":"Gastrointest Endosc"},{"issue":"6","key":"10.1016\/j.gtc.2020.08.005_bib61","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1053\/j.gastro.2016.08.002","article-title":"Comparison of targeted vs random biopsies for surveillance of ulcerative colitis-associated colorectal cancer","volume":"151","author":"Watanabe","year":"2016","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.gtc.2020.08.005_bib62","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1136\/gutjnl-2016-311892","article-title":"Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy?","volume":"67","author":"Moussata","year":"2018","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.gtc.2020.08.005_bib63","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0016-5107(04)01710-9","article-title":"Most dysplasia in ulcerative colitis is visible at colonoscopy","volume":"60","author":"Rutter","year":"2004","journal-title":"Gastrointest Endosc"},{"issue":"7","key":"10.1016\/j.gtc.2020.08.005_bib64","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.gie.2006.09.025","article-title":"Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?","volume":"65","author":"Rubin","year":"2007","journal-title":"Gastrointest Endosc"},{"issue":"2","key":"10.1016\/j.gtc.2020.08.005_bib65","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/ibd.23002","article-title":"Comparison of high definition with standard white light endoscopy for detection of dysplastic lesions during surveillance colonoscopy in patients with colonic inflammatory bowel disease","volume":"19","author":"Subramanian","year":"2013","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"10.1016\/j.gtc.2020.08.005_bib66","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1053\/gast.2003.50146","article-title":"Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis","volume":"124","author":"Kiesslich","year":"2003","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.gtc.2020.08.005_bib67","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1136\/gut.2003.016386","article-title":"Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis","volume":"53","author":"Rutter","year":"2004","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.gtc.2020.08.005_bib68","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1053\/j.gastro.2015.01.031","article-title":"SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease","volume":"148","author":"Laine","year":"2015","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.gtc.2020.08.005_bib69","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.gie.2019.04.219","article-title":"Meta-analysis of dye-based chromoendoscopy compared with standard- and high-definition white-light endoscopy in patients with inflammatory bowel disease at increased risk of colon cancer","volume":"90","author":"Feuerstein","year":"2019","journal-title":"Gastrointest Endosc"},{"issue":"3","key":"10.1016\/j.gtc.2020.08.005_bib70","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1055\/s-2007-966214","article-title":"Narrow-band imaging compared with conventional colonoscopy for the detection of dysplasia in patients with longstanding ulcerative colitis","volume":"39","author":"Dekker","year":"2007","journal-title":"Endoscopy"},{"issue":"2","key":"10.1016\/j.gtc.2020.08.005_bib71","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1055\/s-0030-1255956","article-title":"Narrow-band imaging versus high-definition endoscopy for the diagnosis of neoplasia in ulcerative colitis","volume":"43","author":"van den Broek","year":"2011","journal-title":"Endoscopy"},{"issue":"6","key":"10.1016\/j.gtc.2020.08.005_bib72","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1136\/gutjnl-2016-313213","article-title":"Chromoendoscopy versus narrow band imaging in UC: a prospective randomised controlled trial","volume":"67","author":"Bisschops","year":"2018","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.gtc.2020.08.005_bib73","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0046-8177(83)80175-0","article-title":"Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications","volume":"14","author":"Riddell","year":"1983","journal-title":"Hum Pathol"},{"issue":"10","key":"10.1016\/j.gtc.2020.08.005_bib74","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1136\/gut.35.10.1419","article-title":"Clinicopathological characteristics of colorectal carcinoma complicating ulcerative colitis","volume":"35","author":"Connell","year":"1994","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.gtc.2020.08.005_bib75","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/0046-8177(89)90273-6","article-title":"Observer study of the grading of dysplasia in ulcerative colitis: comparison with clinical outcome","volume":"20","author":"Melville","year":"1989","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.gtc.2020.08.005_bib76","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/path.876","article-title":"Inter-observer variation between general and specialist gastrointestinal pathologists when grading dysplasia in ulcerative colitis","volume":"194","author":"Eaden","year":"2001","journal-title":"J\u00a0Pathol"},{"issue":"2","key":"10.1016\/j.gtc.2020.08.005_bib77","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0016-5085(81)90727-7","article-title":"Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy","volume":"80","author":"Blackstone","year":"1981","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.gtc.2020.08.005_bib78","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0016-5085(99)70279-9","article-title":"Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps","volume":"117","author":"Rubin","year":"1999","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.gtc.2020.08.005_bib79","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0016-5085(99)70278-7","article-title":"Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis","volume":"117","author":"Engelsgjerd","year":"1999","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.gtc.2020.08.005_bib80","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/ecco-jcc\/jjy007","article-title":"Diagnostic yield of dysplasia in polyp-adjacent biopsies for patients with inflammatory bowel disease: a cross-sectional study","volume":"12","author":"Lahiff","year":"2018","journal-title":"J\u00a0Crohns Colitis"},{"issue":"2","key":"10.1016\/j.gtc.2020.08.005_bib81","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.cgh.2016.08.035","article-title":"Low rate of dysplasia detection in mucosa surrounding dysplastic lesions in pa0tients undergoing surveillance for inflammatory bowel diseases","volume":"15","author":"Ten Hove","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.gtc.2020.08.005_bib82","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1002\/ibd.21184","article-title":"Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis","volume":"16","author":"Pekow","year":"2010","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"10.1016\/j.gtc.2020.08.005_bib83","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/ibd.21467","article-title":"Misclassification of dysplasia in patients with inflammatory bowel disease: consequences for progression rates to advanced neoplasia","volume":"17","author":"van Schaik","year":"2011","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"10.1016\/j.gtc.2020.08.005_bib84","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/MIB.0000000000000286","article-title":"Risk for colorectal neoplasia in patients with inflammatory bowel disease and mucosa indefinite for dysplasia","volume":"21","author":"Lai","year":"2015","journal-title":"Inflamm Bowel Dis"},{"issue":"7","key":"10.1016\/j.gtc.2020.08.005_bib85","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/j.cgh.2019.08.032","article-title":"Association between indefinite dysplasia and advanced neoplasia in patients with inflammatory bowel diseases undergoing surveillance","volume":"18","author":"Mahmoud","year":"2020","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Gastroenterology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855320300789?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855320300789?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:30:37Z","timestamp":1760178637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889855320300789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":85,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0889855320300789"],"URL":"https:\/\/doi.org\/10.1016\/j.gtc.2020.08.005","relation":{},"ISSN":["0889-8553"],"issn-type":[{"value":"0889-8553","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of Colon Cancer and Recommended Surveillance Strategies in Patients with Ulcerative Colitis","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gtc.2020.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}